Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study

Corporate Breaking News

Home : Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study

Jul 10 2020	Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study
STOCKHOLM, July 10, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a positive top line result for the company's pivotal phase III study, IsoConDa. The study reached its primary endpoint; to show that IsoConDa (isoflurane), administered with AnaConDa,...


Source:https://www.prnewswire.com:443/news-releases/sedana-medical-announces-positive-top-line-result-in-pivotal-isoconda-study-301091365.html

Related News
» New Nordic Life Science Venture Fund, Eir Ventures, Launched to Leverage the Untapped Potential of Health Care Innovation » Ping An Bank Ranks 46th on Top 1000 World Banks